In no way am I trying to down-ramp, or bring doubt to what will likely be a significant event for Imugene...However, has anyone else had the following thought...
If the onCARlytics (CF33-CD19t oncolytic virus) results are so significant and 'paradigm shifting' - why are they just a abstract/poster readout? Wouldn't they warrant their own presentation/session/seminar?
There are some 850+ poster presentations - are we saying that Abstract #368 is more significant than the results that are actually being 'presented' and formally delivered? If so, why is it given the same time as the other abstracts - or is it a mandate for preclinical/trial results to be abstracts only?
Apologies in advance if what I have stated/asked is ignorant - I've never been to any sort of health/medical conference!
In no way am I trying to down-ramp, or bring doubt to what will...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.9¢ |
Change
-0.004(4.82%) |
Mkt cap ! $578.2M | |||
| Open | High | Low | Value | Volume |
| 8.2¢ | 8.3¢ | 7.7¢ | $1.357M | 17.06M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 735848 | 7.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.0¢ | 328052 | 7 |
View Market Depth
| Last trade - 16.10pm 26/04/2024 (20 minute delay) ? |
|
|||||
|
Last
8.0¢ |
Change
-0.004 ( 4.33 %) |
||||
| Open | High | Low | Volume | ||
| 8.2¢ | 8.2¢ | 7.8¢ | 7785002 | ||
| Last updated 15.59pm 26/04/2024 ? | |||||
| IMU (ASX) Chart |